S. Rota

Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial

Stefano Cascinu, Rossana Berardi, Roberto Labianca et al. · The Lancet Oncology · 2008 · 133 citations

Medicine, Oncology, Pharmacology +11

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

Stefano Cascinu, Roberto Labianca, Carlo Barone et al. · JNCI Journal of the National Cancer Institute · 2007 · 96 citations

Medicine, Oncology, Pharmacology +12

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD)

Stefano Cascinu, Francesco Graziano, Francesco Ferraù et al. · Annals of Oncology · 2002 · 52 citations · Full text

Medicine, Oncology, Chemotherapy +11

Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patients

Stefano Cascinu, Gerardo Rosati, Guglielmo Nasti et al. · European Journal of Cancer · 2017 · 30 citations · Full text

Medicine, Oncology, Pharmacology +13